SYK INHIBITORS

wherein R1, R2, R3, and R4 are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts or co-crystals thereof, and methods of using these compounds and compositions to treat conditions mediate...

Full description

Saved in:
Bibliographic Details
Main Authors Lo, Jennifer R, Blomgren, Peter A, Mitchell, Scott A, Lee, Seung H, Xu, Jianjun, Schmitt, Aaron C, Xiong, Jin-Ming, Zhao, Zhongdong, Kropf, Jeffrey E, Currie, Kevin S, Swaminathan, Sundaramoorthi
Format Patent
LanguageEnglish
Published 26.12.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:wherein R1, R2, R3, and R4 are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts or co-crystals thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk.
Bibliography:Application Number: US201916413458